Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. KLTO
KLTO logo

KLTO

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

KLTO News

Klotho Acquires Greenland Mines, Opening New Chapter

6d agoPRnewswire

Klotho Neurosciences Secures Patent Claims for s-KL Protein

Feb 18 2026PRnewswire

Klotho CEO Dr. Joseph Sinkule to Present at Biotech Showcase on January 13, 2026

Jan 08 2026Newsfilter

Coinbase CEO Armstrong Invests in NewLimit, Secures $45 Million Funding

Jan 06 2026Benzinga

Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award

Nov 07 2025PRnewswire

Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston

Oct 16 2025PRnewswire

Klotho Neurosciences Declares Letter of Intent No Longer Valid

Oct 07 2025Newsfilter

CEO van Klotho Neurosciences neemt deel aan inaugurele conferentie en wetenschappelijk seminar

Sep 09 2025PRnewswire

Le PDG de Klotho Neurosciences participera à la conférence inaugurale et au séminaire scientifique

Sep 09 2025PRnewswire

CEO von Klotho Neurosciences nimmt an Eröffnungskonferenz und wissenschaftlichem Seminar teil

Sep 09 2025PRnewswire

Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar

Sep 08 2025PRnewswire

Docusign Shares Surge Over 8%; Check Out 20 Stocks Making Moves in Premarket Trading

Sep 05 2025Benzinga

Klotho Neurosciences Shares Shareholder Update on Recent Achievements While Preparing to Tackle $8 Billion Neurodegenerative Disease Market

Aug 18 2025Newsfilter

UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Jul 26 2025Yahoo Finance

Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Jul 24 2025Newsfilter

Klotho Neurosciences Partners With AAVnerGene To Accelerate Cost-Effective Gene Therapy Development

Jul 23 2025NASDAQ.COM